Should clopidogrel be discontinued before laparoscopic cholecystectomy?

Katherine Anderson, Daniel Jupiter, Stephen W. Abernathy, Richard C. Frazee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background The perioperative management of clopidogrel remains an area of controversy.

Methods An institutional review board-approved retrospective review of patients undergoing a laparoscopic cholecystectomy while on clopidogrel from 2008 to 2012 was performed. These patients were then matched with a nonclopidogrel cohort based on American Society of Anesthesiologists score and emergent or elective surgery. Intraoperative estimated blood loss, operative time, length of stay, and 30-day morbidity were compared.

Results Thirty-six clopidogrel and 36 control patient records were analyzed. There were no significant differences in age, body mass index, sex, or incidence of coronary artery disease, diabetes, hyperlipidemia, and congestive heart failure. Estimated blood loss averaged 50 mL in the clopidogrel group and 47 mL in the control group (P = nonsignificant). There were no significant differences in operative time, 30-day morbidity, or length of stay between the 2 groups.

Conclusions Laparoscopic cholecystectomy performed on patients maintained on clopidogrel during the perioperative period did not produce an increase in blood loss, operative time, 30-day morbidity, or length of stay.

Original languageEnglish (US)
Pages (from-to)926-931
Number of pages6
JournalAmerican Journal of Surgery
Volume208
Issue number6
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

clopidogrel
Laparoscopic Cholecystectomy
Operative Time
Length of Stay
Morbidity
Perioperative Period
Research Ethics Committees
Hyperlipidemias
Coronary Artery Disease
Body Mass Index
Heart Failure
Control Groups

Keywords

  • Bleeding complications
  • Laparoscopic cholecystectomy
  • Perioperative clopidogrel

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Should clopidogrel be discontinued before laparoscopic cholecystectomy? / Anderson, Katherine; Jupiter, Daniel; Abernathy, Stephen W.; Frazee, Richard C.

In: American Journal of Surgery, Vol. 208, No. 6, 01.12.2014, p. 926-931.

Research output: Contribution to journalArticle

Anderson, Katherine ; Jupiter, Daniel ; Abernathy, Stephen W. ; Frazee, Richard C. / Should clopidogrel be discontinued before laparoscopic cholecystectomy?. In: American Journal of Surgery. 2014 ; Vol. 208, No. 6. pp. 926-931.
@article{bd55875432e04e1e9fe79fc103bfd62b,
title = "Should clopidogrel be discontinued before laparoscopic cholecystectomy?",
abstract = "Background The perioperative management of clopidogrel remains an area of controversy.Methods An institutional review board-approved retrospective review of patients undergoing a laparoscopic cholecystectomy while on clopidogrel from 2008 to 2012 was performed. These patients were then matched with a nonclopidogrel cohort based on American Society of Anesthesiologists score and emergent or elective surgery. Intraoperative estimated blood loss, operative time, length of stay, and 30-day morbidity were compared.Results Thirty-six clopidogrel and 36 control patient records were analyzed. There were no significant differences in age, body mass index, sex, or incidence of coronary artery disease, diabetes, hyperlipidemia, and congestive heart failure. Estimated blood loss averaged 50 mL in the clopidogrel group and 47 mL in the control group (P = nonsignificant). There were no significant differences in operative time, 30-day morbidity, or length of stay between the 2 groups.Conclusions Laparoscopic cholecystectomy performed on patients maintained on clopidogrel during the perioperative period did not produce an increase in blood loss, operative time, 30-day morbidity, or length of stay.",
keywords = "Bleeding complications, Laparoscopic cholecystectomy, Perioperative clopidogrel",
author = "Katherine Anderson and Daniel Jupiter and Abernathy, {Stephen W.} and Frazee, {Richard C.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.amjsurg.2014.08.001",
language = "English (US)",
volume = "208",
pages = "926--931",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Should clopidogrel be discontinued before laparoscopic cholecystectomy?

AU - Anderson, Katherine

AU - Jupiter, Daniel

AU - Abernathy, Stephen W.

AU - Frazee, Richard C.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background The perioperative management of clopidogrel remains an area of controversy.Methods An institutional review board-approved retrospective review of patients undergoing a laparoscopic cholecystectomy while on clopidogrel from 2008 to 2012 was performed. These patients were then matched with a nonclopidogrel cohort based on American Society of Anesthesiologists score and emergent or elective surgery. Intraoperative estimated blood loss, operative time, length of stay, and 30-day morbidity were compared.Results Thirty-six clopidogrel and 36 control patient records were analyzed. There were no significant differences in age, body mass index, sex, or incidence of coronary artery disease, diabetes, hyperlipidemia, and congestive heart failure. Estimated blood loss averaged 50 mL in the clopidogrel group and 47 mL in the control group (P = nonsignificant). There were no significant differences in operative time, 30-day morbidity, or length of stay between the 2 groups.Conclusions Laparoscopic cholecystectomy performed on patients maintained on clopidogrel during the perioperative period did not produce an increase in blood loss, operative time, 30-day morbidity, or length of stay.

AB - Background The perioperative management of clopidogrel remains an area of controversy.Methods An institutional review board-approved retrospective review of patients undergoing a laparoscopic cholecystectomy while on clopidogrel from 2008 to 2012 was performed. These patients were then matched with a nonclopidogrel cohort based on American Society of Anesthesiologists score and emergent or elective surgery. Intraoperative estimated blood loss, operative time, length of stay, and 30-day morbidity were compared.Results Thirty-six clopidogrel and 36 control patient records were analyzed. There were no significant differences in age, body mass index, sex, or incidence of coronary artery disease, diabetes, hyperlipidemia, and congestive heart failure. Estimated blood loss averaged 50 mL in the clopidogrel group and 47 mL in the control group (P = nonsignificant). There were no significant differences in operative time, 30-day morbidity, or length of stay between the 2 groups.Conclusions Laparoscopic cholecystectomy performed on patients maintained on clopidogrel during the perioperative period did not produce an increase in blood loss, operative time, 30-day morbidity, or length of stay.

KW - Bleeding complications

KW - Laparoscopic cholecystectomy

KW - Perioperative clopidogrel

UR - http://www.scopus.com/inward/record.url?scp=84916619855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916619855&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2014.08.001

DO - 10.1016/j.amjsurg.2014.08.001

M3 - Article

C2 - 25435299

AN - SCOPUS:84916619855

VL - 208

SP - 926

EP - 931

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -